TickerFactsScreenerDevelopers

Vistagen Therapeutics, Inc. (VTGN) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $201.0K2011: $139.3K2012: $81.0K2013: $638.1K2015: $70.0K2016: $428.5K2017: $2.92M2018: $10.38M2019: $13.10M2020: $1.36M2021: $103.11M2022: $68.14M2023: $16.64M2024: $119.17M2025: $67.13M2026: $30.79M$30.79M
2010Cash & Equivalents (USD)2026
Fiscal YearCash & EquivalentsChange YoY
2026$30.79M-54.1%
2025$67.13M-43.7%
2024$119.17M+616.2%
2023$16.64M-75.6%
2022$68.14M-33.9%
2021$103.11M+7508.9%
2020$1.36M-89.7%
2019$13.10M+26.2%
2018$10.38M+255.3%
2017$2.92M+581.8%
2016$428.5K+512.1%
2015$70.0K—
2013$638.1K+687.8%
2012$81.0K-41.9%
2011$139.3K-30.7%
2010$201.0K—